HK Stock Market Move | TH MEDICAL-B (02697) rose over 8%, with a total market value exceeding HKD 30 billion. The room temperature mechanical infusion business is expected to experience strong growth.

TH MEDICAL-B (02697) has continued to rise since its listing, reaching a high of HKD 886 during today's trading, representing an increase of over 600% from the offering price of HKD 126.2, with a total market value exceeding HKD 30 billion. By the close, it had risen 8.62% to HKD 875.5, with a trading volume of HKD 27.1359 million. In terms of news, True Health Medical recently announced that it has officially won the bid for the equipment procurement project of the Key Laboratory for Gene Editing of Small Pigs and Heterogeneous Organ Transplantation at Yunnan Agricultural University (Project No.: YNGH[2026]-0626), with a total contract value of RMB 2.8 million. The procurement involves a multi-organ, multi-sensor normothermic perfusion system with an integrated ventilator, which will be used for cross-perfusion research of heterogeneous multi-organs at normothermia. The Board of Directors stated that this successful bid reflects the market's recognition of the Group's products and technological capabilities, and it is expected to enhance the Group's market influence and business expansion ability in the field of scientific research medical equipment. Analysts note that this breakthrough for the laboratory is just the starting point; as the clinical demand for heterogeneous transplantation and organ repair surges, True Health Medical's second growth curve has entered a visible phase of robust volume expansion, opening up significant future valuation possibilities.